Suchergebnisse - "Perez, Edith A"

PubPharm (673)

1

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

enthalten in: ResearchSquare.com | 2024

von Mezzanotte-Sharpe, J. | ONeill, A. | Mayer, I. | +19

2

Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival

enthalten in: JAMA network open | 2023

von Lipsyc-Sharf, M. | Ballman, K. | Campbell, J. | +6

ErratumIn: JAMA Netw Open. 2023 Nov 1;6(11):e2348174. - PMID 38032646

3

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

enthalten in: Nature communications | 2023

von Carter, J. | Chumsri, S. | Hinerfeld, D. | +23

4

Understanding Modern Medical Centers : Beyond Simone-Intersectional Maxims for a New Era

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Graff, S. | Wildes, T. | Duma, N. | +8

5

Miz1 promotes KRAS-driven lung tumorigenesis by repressing the protocadherin Pcdh10

enthalten in: Cancer letters | 2023

von Yang, J. | Hou, C. | Wang, H. | +14

6

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

enthalten in: Frontiers in oncology | 2023

von Advani, P. | Ruddy, K. | Herrmann, J. | +16

7

Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer : a literature review

enthalten in: Breast cancer research and treatment | 2022

von Perez, E. | Dang, C. | Lee, C. | +6

8

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients : A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial

enthalten in: Clinical breast cancer | 2022

von Caparica, R. | Ma, Y. | De Angelis, C. | +9

9

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

enthalten in: NPJ breast cancer | 2022

von Chumsri, S. | Li, Z. | Serie, D. | +22

10

Incidence of adverse events with therapies targeting HER2-positive metastatic breast cancer: a literature review

enthalten in: Breast cancer research and treatment | 2022

von Perez, E. | Dang, C. | Lee, C. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[68]